FDA.reportPublic FDA data

2.4 ML tirzepatide 25 MG/ML Pen Injector [Mounjaro]

RxCUI
2735297
RxNorm name
2.4 ML tirzepatide 25 MG/ML Pen Injector [Mounjaro]
Display name
2.4 ML tirzepatide 25 MG/ML Pen Injector [Mounjaro]
Full name
2.4 ML tirzepatide 25 MG/ML Pen Injector [Mounjaro]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MounjaroTIRZEPATIDEEli Lilly and Companyd2d7da5d-ad07-4228-955f-cf7e355c8cc02026-04-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2735297

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d2d7da5d-ad07-4228-955f-cf7e355c8cc0mounjaro 15 MG per dose (60 MG in 2.4 ML) Pen Injector [PSN] · 2.4 ML tirzepatide 25 MG/ML Pen Injector [Mounjaro] [SBD] · Mounjaro 60 MG per 2.4 ML Pen Injector [SY]338These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422